full-term infant who was rescued from hvperammonemic coma at 
Studies from this laboratory have suggested that supplementation of a low-protein diet with a mixture of essential amino acids and their nitrogen-free analogues can sustain normal growth in children with congenital defects of the urea cycle (6) . However, in most of these cases, a hyperammonemic crisis occurred during the first 2 years of life and proved fatal (13, 15, 17) .
We have reported that plasma a-ketoglutarate concentration ([a-KG]) is inversely correlated with plasma ammonium concentration, [NH,'] , in low-birth-weight infants (2) . Previous studies of [a-KG] in liver disease, however, suggest these levels may be increased (8, 12) . We now report studies of this relationship in patients with congenital urea cycle defects and portal-systemic encephalopathy. We also present metabolic observations from the early stages of hyperammonemic coma in two male infants with ornithine transcarbamylase (OTC) deficiency. These observations suggest that plasma [a-KG] becomes subnormal before the development of hyperammonemic coma and may be a harbinger of coma in patients with urea cycle defects.
SUBJECTS
UREA CYCLE ENZYMOPATHIES 4 days of age by the use of peritoneal d;ilysis. He was placed on a protein-restricted diet supplemented with essential amino acids and their nitrogen-free analogs as previously described (17) . At 2 wk of age, he received 120 kcal/kg/day and 2 g protein/kg/day. He gained an average of 20 g/day during the succeeding month. Developmental and neurologic examination and electroencephalogram at five wk of age were within normal limits.
The infant's clinical condition remained stable until 49 days of age when he developed vomiting and lethargy. Plasma [NH,'] increased to 150 pM, and urinary orotic acid increased to 5017 pg/mg creatinine. He became comatose on day 51 after which peritoneal dialysis was begun. The electroencephalogram became isoelectric at 55 days of age, and life support systems were discontinued. Liver obtained by percutaneous biopsy had 3.6% of normal activity of OTC and normal activities of the other four urea cycle enzymes.' This paper describes the metabolic events during his final 5 wk of life.
The second male, R. D., was also rescued from hyperammonemic coma by peritoneal dialysis. He was placed on a similar dietary regimeh i s patient C. $ However, h i experienced intermittent hyperammonemic episodes throughout his life, was profoundly mentally retarded, and required tube feedings. His height and weight were within normal limits. However, his head circumference was below the third percentile. This study describes the metabolic events during a reversible hyperammonemic episode at 13 months of age. As with previous episodes, the child had recurrent vomiting and became stuperous over a 2-day period. On this occasion, he responded to conservative management including administration of 2 g sodium benzoate (7). He did not survive a similar episode at 15 months of age. Liver obtained at time of death had 0.05% of normal activity of OTC and normal activities of the other four urea cycle enzymes.' In addition to these patients, six other children with urea cycle enzymopathies were studied. They included two patients with partial OTC deficiency, one with partial carbamyl phosphate synthetase deficiency, two with argininosuccinic acid synthetase deficiency, and one with argininosuccinase deficiency. They were all asymptomatic while variously treated with protein restriction, nitrogen-free analogues of essential amino acids and dietary arginine supplementation (Table 1) .
PORTAL SYSTEMIC ENCEPHALOPATHY (PSE)
Five adults with PSE were also studied. All had biopsy-proven chronic liver disease (either alcoholic cirrhosis or post-necrotic cirrhosis) with varying degrees of hepatocellular dysfunction. All had some degree of hyperammonemia during the study ( (9) ] remained normal or near normal until 40 days of age when it rose to 57 pM. However, this hyperammonemia was preceded by a fall in the plasma [a-KG] at 27 days of age (15 pM) to be followed in sequence by increased levels of glutamine (998 pM) and glutamate (146 pM) at 36 and 40 days of age, respectively.
RESULTS

RELATIONSHIP BETWEEN [NHI*] AND [a-KG]
It was only after severe hyperammonemia was established at 50 days of age that coma supervened. Figure 2 shows the pattern of metabolic abnormalities in patient R. D. during a reversible episode of hyperammonemic coma at 13 months of age. The sequence of biochemical abnormalities preceding hyperammonemic coma was similar to that noted in C. S. Plasma [a-KG] became subnormal on day 1 (14 pM) followed by increasing levels of glutamate (102 pM) and glutamine (840 pM) on days 7 and 8. Plasma [NH4'] became abnormal (52 pM) on day 9. The child became stuporous on day 14. Thus, in both C. S. and R. D., plasma a-KG became abnormally Ibw 1 to 2 wk before clipically significant hyperammonemia was evident. Furthermore, the finding of different [a-KG] levels in patients with hyperammonemia secondary to urea cycle enzymo~athies as compir6d to patients with portal systemic e i~e~h a l 6~a t 6~ implies different pathophysiologic mechanisms of coma in these two disorders.
